| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.15 | 0.005 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.005 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.093 | 0.005 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.005 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.13 | 0.006 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.089 | 0.007 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.007 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.007 |